Higher serum uric acid associates with better cognitive performance and survival in Caribbean parkinsonism.

Tanicia Mameri R. Edragas A. Chavonnet B. Tressières Loic Dragin Angela Lackmy Véronique Pelonde-Erimée Stanie Gaete Regine Hierso Pierre Pouget Emmanuel Roze P. Michel Annie Lannuzel

Sep 2026 · Journal of neural transmission · 0 citations · 47 references

Medicine

TL;DR

Findings provide further evidence supporting the relevance of UA to the pathogenesis of neurodegenerative parkinsonism and offer opportunities for risk stratification and the investigation of UA-related interventions in patients with Caribbean parkinsonism.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Aug 2026

Reduced serum Klotho in chronic schizophrenia: diagnostic value and association with cognitive impairment

Objective To investigate the correlation between serum Klotho levels and cognitive function in individuals with chronic Schizophrenia (SZ). Methods A total of 108 patients diagnosed with chronic SZ and 83 age-matched healthy controls were recruited from four psychiatric specialist hospitals in Lianyungang from January...

Dongliang Liu, Huayu Ma, Man Yang et al. · Frontiers in Psychiatry · 0 citations

Open access Sep 2026

Serum Uric Acid and Amyotrophic Lateral Sclerosis Progression: An Exploratory Analysis of Potential Riluzole Interaction

Baseline UA was not significantly associated with functional decline or survival, and riluzole did not significantly modify the UA–progression association, and Larger multicenter studies with repeated UA measurements are warranted.

Hui-Hong Tian, Nan Hu, Ming Qi et al. · Neurology and Clinical Neuro... · 0 citations

Open access Aug 2026

Serum 25-hydroxyvitamin D and cognitive performance in hospitalized older adults: a cross-sectional study from Central Poland

Higher serum 25(OH)D concentration was associated with better cognitive performance and lower odds of cognitive impairment and documented dementia in hospitalized older adults, with adjustment for age, sex, BMI, albumin concentration, depressive symptoms, and history of stroke.

Ganna Kravchenko, S. S. Stephenson, Julia Dmuchowska et al. · Frontiers in Nutrition · 0 citations

Open access Sep 2026

Association Between Blood Cadmium Levels and Cognitive Function in Patients with Parkinson’s Disease: A Pilot Study

Keeping in mind the neurological toxicity of Cadmium (Cd) and its possible association with Parkinson’s disease (PD), the present study has been designed to explore whether higher blood Cd levels are a risk factor for advanced cognitive deterioration in patients with PD. The aim of this study was to determine the blo...

Richa Choudhary, Akshay R. Singh, S. Narayan et al. · Journal of Indian Academy of... · 0 citations

Sep 2026

The link between plasma and cognitive markers for Alzheimer’s disease in Down syndrome: a longitudinal study

Findings highlight the relevance of episodic memory performance as a predictor of biomarker progression, particularly p-tau217, and support its close association with clinical status and disease progression, and the development of screening strategies to identify DS individuals at high risk of rapid cognitive decline.

Alberto Fernández, E. Molanes-López, Pilar Zuluaga et al. · Journal of Neurology · 0 citations

Oct 2026

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

BACKGROUND Circulating phosphatidylserine (cPS) may reflect neuronal injury in Parkinson's disease (PD), yet its diagnostic and prognostic utility remains unvalidated. This study aimed to evaluate cPS as a plasma biomarker for PD staging and outcome prediction. METHODS In this 24-month prospective cohort (STARD-compl...

Hai-Qing Shen, Pei-Li Sun, Bei-Hai Ge et al. · Clinical Biochemistry · 0 citations